A detailed history of Johnson Financial Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 2,757 shares of REGN stock, worth $2.25 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,757
Previous 913 201.97%
Holding current value
$2.25 Million
Previous $878,000 229.95%
% of portfolio
0.14%
Previous 0.05%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $1.63 Million - $1.98 Million
1,844 Added 201.97%
2,757 $2.9 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $41,523 - $45,694
46 Added 5.31%
913 $878,000
Q4 2023

Feb 09, 2024

SELL
$775.18 - $881.7 $198,446 - $225,715
-256 Reduced 22.8%
867 $761,000
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $142,644 - $173,940
-206 Reduced 15.5%
1,123 $924,000
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $118,305 - $140,329
-169 Reduced 11.28%
1,329 $954,000
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $223,881 - $272,073
329 Added 28.14%
1,498 $1.23 Million
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $14,117 - $15,327
20 Added 1.74%
1,169 $843,000
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $119,959 - $151,382
-209 Reduced 15.39%
1,149 $856,000
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $19,740 - $26,598
36 Added 2.72%
1,358 $803,000
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $32,136 - $37,715
54 Added 4.26%
1,322 $923,000
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $61,413 - $75,819
113 Added 9.78%
1,268 $801,000
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $52,236 - $61,967
-91 Reduced 7.3%
1,155 $699,000
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $61,464 - $72,610
130 Added 11.65%
1,246 $696,000
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $21,443 - $26,313
-48 Reduced 4.12%
1,116 $528,000
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $17,218 - $21,887
-36 Reduced 3.0%
1,164 $562,000
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $119,300 - $144,147
219 Added 22.32%
1,200 $672,000
Q2 2020

Aug 11, 2020

SELL
$493.32 - $643.92 $51,305 - $66,967
-104 Reduced 9.59%
981 $612,000
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $8,740 - $12,855
-26 Reduced 2.34%
1,085 $530,000
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $578,414 - $794,436
-2,110 Reduced 65.51%
1,111 $417,000
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $73,834 - $85,965
270 Added 9.15%
3,221 $893,000
Q2 2019

Aug 09, 2019

BUY
$299.6 - $414.82 $204,327 - $282,907
682 Added 30.06%
2,951 $923,000
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $130,600 - $154,289
351 Added 18.3%
2,269 $931,000
Q4 2018

Feb 11, 2019

BUY
$335.82 - $403.04 $627,311 - $752,878
1,868 Added 3736.0%
1,918 $716,000
Q3 2017

Nov 09, 2017

BUY
$431.38 - $504.0 $21,569 - $25,200
50
50 $22,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $87.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.